Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

Omicron evades immunity better than Delta, Danish study finds

Published 01/03/2022, 08:48 AM
Updated 01/03/2022, 08:51 AM
© Reuters. FILE PHOTO: A doctor shows vials of Biontech-Pfizer's Comirnaty vaccine against COVID-19 at the Institute for Health and Food Safety of Zenica, Bosnia and Herzegovina, December 16, 2021. REUTERS/Dado Ruvic

COPENHAGEN (Reuters) - The Omicron coronavirus variant is better at circumventing vaccinated peoples' immunity than the Delta variant, according to a Danish study published last week, helping explain why Omicron is spreading more rapidly.

Since the discovery of the heavily mutated Omicron variant in November, scientists have been racing to find out whether it causes less serious disease and why it appears more contagious than the previously dominating Delta variant.

A virus can be more transmissible due to a number of reasons, such as the time it lingers in the air, its ability to latch onto cells, or its evasion of the body's immune system.

Investigating nearly 12,000 Danish households in mid-December, the scientists found that Omicron was 2.7 to 3.7 times more infectious than the Delta variant among vaccinated Danes.

The study, conducted by researchers at University of Copenhagen, Statistics Denmark and Statens Serum Institut (SSI), suggests the virus is mainly spreading more rapidly because it is better at evading immunity obtained from vaccines.

"Our findings confirm that the rapid spread of the Omicron (variant) primarily can be ascribed to the immune evasiveness rather than an inherent increase in the basic transmissibility," the researchers said. The study has yet to be peer-reviewed.

Seventy-eight percent of Danes have been fully vaccinated, while nearly 48% of those have received a third "boosted" shot. More than eight out of ten Danes have received Pfizer-BioNTech's vaccine.

The study also found that booster-vaccinated people are less likely to transmit the virus, regardless of the variant, than the unvaccinated.

While more transmissible, the Omicron variant does seem to induce less serious disease, SSI's technical director, Tyra Grove Krause, told local media on Monday.

"While Omicron will still be able to put pressure on our healthcare system, everything indicates that it is milder than the Delta variant," she said, adding the risk of being hospitalised with Omicron was half of that with Delta.

That echoes the results of some other studies into Omicron.

© Reuters. FILE PHOTO: A doctor shows vials of Biontech-Pfizer's Comirnaty vaccine against COVID-19 at the Institute for Health and Food Safety of Zenica, Bosnia and Herzegovina, December 16, 2021. REUTERS/Dado Ruvic

Out of a total of 93 people admitted to hospital due to COVID-19 from Omicron in late December, less than five were receiving intensive care, Danish data showed.

"This may be what is going to lift us out of the pandemic, so that this becomes the last wave of corona," Krause said.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.